SHREE GANESH REMEDIES
Back to All Ratios
|
SHREE GANESH REMEDIES Last 5 Year EBIT Margin History
[Consolidated]
Mar2024 | Mar2020 | Mar2019 | |
---|---|---|---|
EBIT Margin(%) | 29.97 | 22.08 | 25.12 |
What is the latest EBIT Margin ratio of SHREE GANESH REMEDIES ?
Year | EBIT Margin |
---|---|
Mar2024 | 29.97 |
Mar2020 | 22.08 |
Mar2019 | 25.12 |
How is EBIT Margin of SHREE GANESH REMEDIES Trending?
Years | EBIT Margin | % Change | |
---|---|---|---|
Mar2024 | 29.97 | 35.73 | |
Mar2020 | 22.08 | -12.10 | |
Mar2019 | 25.12 | - |
Other Financial Ratios of SHREE GANESH REMEDIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹737.1 Cr | 0.3% | 0.8% | -33% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 0.3% |
0.8% |
-33% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses